176 related articles for article (PubMed ID: 36207236)
1. Volumetric Intensity-Modulated Arc Stereotactic Radiosurgery Boost in Oligometastatic Patients with Spine Metastases: a Dose-escalation Study.
Deodato F; Pezzulla D; Cilla S; Ferro M; Giannini R; Romano C; Boccardi M; Buwenge M; Valentini V; Morganti AG; Macchia G
Clin Oncol (R Coll Radiol); 2023 Jan; 35(1):e30-e39. PubMed ID: 36207236
[TBL] [Abstract][Full Text] [Related]
2. Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results.
Macchia G; Deodato F; Cilla S; Torre G; Corrado G; Legge F; Gambacorta MA; Tagliaferri L; Mignogna S; Scambia G; Valentini V; Morganti AG; Ferrandina G
Oncol Rep; 2014 Nov; 32(5):2237-43. PubMed ID: 25175950
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2).
Deodato F; Cilla S; Macchia G; Torre G; Caravatta L; Mariano G; Mignogna S; Ferro M; Mattiucci GC; Balducci M; Frascino V; Piermattei A; Ferrandina G; Valentini V; Morganti AG
Clin Oncol (R Coll Radiol); 2014 Dec; 26(12):748-56. PubMed ID: 25175042
[TBL] [Abstract][Full Text] [Related]
4. Impact of cervicothoracic region stereotactic spine radiosurgery on adjacent organs at risk.
Sharma M; Bennett EE; Rahmathulla G; Chao ST; Koech HK; Gregory SN; Emch T; Magnelli A; Meola A; Suh JH; Angelov L
Neurosurg Focus; 2017 Jan; 42(1):E14. PubMed ID: 28041323
[TBL] [Abstract][Full Text] [Related]
5. Outcomes After Hypofractionated Dose-Escalation using a Simultaneous Integrated Boost Technique for Treatment of Spine Metastases Not Amenable to Stereotactic Radiosurgery.
Farooqi A; Bishop AJ; Narang S; Allen PK; Li J; McAleer MF; Tatsui CE; Rhines LD; Amini B; Wang XA; Ghia AJ
Pract Radiat Oncol; 2019 Mar; 9(2):e142-e148. PubMed ID: 30385151
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results.
Fiorentino A; Giaj-Levra N; Tebano U; Mazzola R; Ricchetti F; Fersino S; Di Paola G; Aiello D; Ruggieri R; Alongi F
Radiol Med; 2017 Sep; 122(9):676-682. PubMed ID: 28447313
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Outcomes After Stereotactic Radiosurgery for Spine Metastases: Radiation Dose-Response for Late Toxicity.
Ling DC; Flickinger JC; Burton SA; Heron DE; Quinn AE; Bejjani GK; Engh JA; Gerszten PC; Amankulor NM; Vargo JA
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):602-609. PubMed ID: 29678526
[TBL] [Abstract][Full Text] [Related]
8. Single fraction spine stereotactic ablative body radiotherapy with volumetric modulated arc therapy.
Gestaut MM; Thawani N; Kim S; Gutti VR; Jhavar S; Deb N; Morrow A; Ward RA; Huang JH; Patel M
J Neurooncol; 2017 May; 133(1):165-172. PubMed ID: 28409420
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated stereotactic body radiotherapy in spinal metastasis - with or without epidural extension.
Anand AK; Venkadamanickam G; Punnakal AU; Walia BS; Kumar A; Bansal AK; Singh HM
Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):345-52. PubMed ID: 25726363
[TBL] [Abstract][Full Text] [Related]
10. Dose fall-off patterns with volumetric modulated arc therapy and three-dimensional conformal radiotherapy including the "organ at risk" effect. Experience of linear accelerator-based frameless radiosurgery from a single institution.
Munshi A; Sarkar B; Roy S; Ganesh T; Mohanti BK
Cancer Radiother; 2019 Apr; 23(2):138-146. PubMed ID: 30797691
[TBL] [Abstract][Full Text] [Related]
11. Five-Year Outcomes of High-Dose Single-Fraction Spinal Stereotactic Radiosurgery.
Moussazadeh N; Lis E; Katsoulakis E; Kahn S; Svoboda M; DiStefano NM; McLaughlin L; Bilsky MH; Yamada Y; Laufer I
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):361-7. PubMed ID: 26232858
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY-2 clinical trial subanalysis.
Deodato F; Pezzulla D; Cilla S; Ferro M; Romano C; Bonome P; Buwenge M; Zamagni A; Strigari L; Valentini V; Morganti AG; Macchia G
Clin Transl Oncol; 2022 Jun; 24(6):1177-1183. PubMed ID: 34984604
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost in Patients With Spinal Metastases.
Pontoriero A; Iatì G; Cacciola A; Conti A; Brogna A; Siragusa C; Ferini G; Davì V; Tamburella C; Molino L; Cambareri D; Severo C; Parisi S; Settineri N; Ielo I; Pergolizzi S
Technol Cancer Res Treat; 2020; 19():1533033820904447. PubMed ID: 32336255
[TBL] [Abstract][Full Text] [Related]
14. Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma.
Miller JA; Balagamwala EH; Angelov L; Suh JH; Rini B; Garcia JA; Ahluwalia M; Chao ST
J Neurosurg Spine; 2016 Dec; 25(6):766-774. PubMed ID: 27391397
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.
Siva S; Kirby K; Caine H; Pham D; Kron T; Te Marvelde L; Whalley D; Stevens MJ; Foroudi F; MacManus M; Ball D; Eade T
Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):353-61. PubMed ID: 25698068
[TBL] [Abstract][Full Text] [Related]
16. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
17. Volumetric modulated arc therapy treatment planning of thoracic vertebral metastases using stereotactic body radiotherapy.
Mallory M; Pokhrel D; Badkul R; Jiang H; Lominska C; Wang F
J Appl Clin Med Phys; 2018 Mar; 19(2):54-61. PubMed ID: 29349867
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic Body Radiotherapy for Spinal Metastases: Clinical Experience in 134 Cases From a Single Japanese Institution.
Ito K; Ogawa H; Shimizuguchi T; Nihei K; Furuya T; Tanaka H; Karasawa K
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806472. PubMed ID: 30355246
[TBL] [Abstract][Full Text] [Related]
19. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
20. SBRT-SG-01: final results of a prospective multicenter study on stereotactic body radiotherapy for liver metastases.
Rodríguez MR; Chen-Zhao X; Hernando O; Flamarique S; Fernández-Letón P; Campo M; López M; Rodríguez M; Zucca D; Martínez D; Sánchez-Saugar E; Mañeru F; Ruiz-Zorrilla JG; de Acilu PG; Valero J; Montero A; Ciérvide R; Alvarez B; García-Aranda M; Alonso R; de la Casa MA; Alonso L; Nuñez M; Martí J; Arias F
Clin Transl Oncol; 2024 Jul; 26(7):1790-1797. PubMed ID: 38431539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
